[Federal Register Volume 70, Number 228 (Tuesday, November 29, 2005)]
[Notices]
[Pages 71558-71559]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E5-6602]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on May 6, 2005, Chemic 
Laboratories, Inc., 480 Neponset Street, Building 7C, Canton, 
Massachusetts 02021, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Cocaine (9041), a basic class of controlled substance 
listed in Schedule II.
    The company plans to manufacture small quantities of a cocaine 
derivative for distribution to its customers for the purpose of 
research.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance

[[Page 71559]]

may file comments or objections to the issuance of the proposed 
registration pursuant to 21 CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than January 30, 2006.

    Dated: November 18, 2005.
Joseph T. Rannazzisi,
Acting Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration.
[FR Doc. E5-6602 Filed 11-28-05; 8:45 am]
BILLING CODE 4410-09-P